{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:06Z","timestamp":1790456286447,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00535-026-02485-3","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:48:09Z","timestamp":1785692889000},"page":"1382-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S1P receptor modulators for moderate-to-severe ulcerative colitis: a systematic review, meta-analysis, and trial sequential analysis"],"prefix":"10.1007","volume":"61","author":[{"given":"Abdulkareem","family":"Jomaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Bshara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilind","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Rajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Hayder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8035-2443","authenticated-orcid":false,"given":"Halder J.","family":"Abozait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Jomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weys","family":"Neda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Najim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Al-Obaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,2]]},"reference":[{"issue":"10401","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402(10401):571\u201384.","journal-title":"Lancet"},{"issue":"10","key":"2485_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951\u201365.","journal-title":"JAMA"},{"issue":"7","key":"2485_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S2468-1253(22)00001-2","volume":"7","author":"PG Kotze","year":"2022","unstructured":"Kotze PG, Heuthorst L, Lightner AL, et al. New insights on the surgical management of ulcerative colitis in the 21st century. Lancet Gastroenterol Hepatol. 2022;7(7):679\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"2485_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1053\/j.gastro.2024.07.046","volume":"167","author":"AN Ananthakrishnan","year":"2024","unstructured":"Ananthakrishnan AN, Murad MH, Scott FI, et al. Comparative efficacy of advanced therapies for management of moderate-to-severe ulcerative colitis: 2024 American Gastroenterological Association Evidence Synthesis. Gastroenterology. 2024;167(7):1460\u201382.","journal-title":"Gastroenterology"},{"issue":"10341","key":"2485_CR5","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","volume":"399","author":"S Danese","year":"2022","unstructured":"Danese S, Vermeire S, Zhou W, et al. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. Lancet. 2022;399(10341):2113\u201328.","journal-title":"Lancet"},{"issue":"13","key":"2485_CR6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands BE, Sandborn WJ, Panaccione R, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2019;381(13):1201\u201314.","journal-title":"N Engl J Med"},{"issue":"6","key":"2485_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025;120(6):1187\u2013224.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2485_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/apt.16712","volume":"55","author":"WJ Sandborn","year":"2022","unstructured":"Sandborn WJ, Lawendy N, Danese S, et al. Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE open, an open-label, long-term extension study with up to 7.0 years of treatment. Aliment Pharmacol Ther. 2022;55(4):464\u201378.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2019.08.027","volume":"158","author":"WJ Sandborn","year":"2020","unstructured":"Sandborn WJ, Baert F, Danese S, et al. Efficacy and safety of vedolizumab subcutaneous formulation in a randomized trial of patients with ulcerative colitis. Gastroenterology. 2020;158(3):562-72.e12.","journal-title":"Gastroenterology"},{"key":"2485_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103475","author":"XY Choon","year":"2025","unstructured":"Choon XY, Yeo JH, White C, et al. The current sphingosine 1 phosphate receptor modulators in the management of ulcerative colitis. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14103475.","journal-title":"J Clin Med"},{"key":"2485_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100812","author":"H Nakase","year":"2026","unstructured":"Nakase H, Fujii T, Hisamatsu T, et al. Once-daily oral ozanimod for Japanese patients with ulcerative colitis: results from the phase 2\/3 J-True North study. Gastro Hep Adv. 2026. https:\/\/doi.org\/10.1016\/j.gastha.2025.100812.","journal-title":"Gastro Hep Adv"},{"issue":"12","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S2468-1253(25)00198-0","volume":"10","author":"K Wu","year":"2025","unstructured":"Wu K, Zheng C, Cao Q, et al. Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study. Lancet Gastroenterol Hepatol. 2025;10(12):1089\u2013103.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2485_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S2468-1253(24)00386-8","volume":"10","author":"BE Sands","year":"2025","unstructured":"Sands BE, Panaccione R, D\u2019Haens G, et al. Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial. Lancet Gastroenterol Hepatol. 2025;10(3):210\u201321.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2485_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000509393","volume":"5","author":"HH Radeke","year":"2020","unstructured":"Radeke HH, Stein J, Van Assche G, et al. A multicentre, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of the s1p receptor agonist KRP203 in patients with moderately active refractory ulcerative colitis. Inflamm Intest Dis. 2020;5(4):180\u201390.","journal-title":"Inflamm Intest Dis"},{"issue":"15","key":"2485_CR15","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.3390\/jcm12155014","volume":"12","author":"S Bencardino","year":"2023","unstructured":"Bencardino S, D\u2019Amico F, Faggiani I, et al. Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. J Clin Med. 2023;12(15):5014.","journal-title":"J Clin Med"},{"issue":"6","key":"2485_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41575-021-00574-7","volume":"19","author":"B Verstockt","year":"2022","unstructured":"Verstockt B, Vetrano S, Salas A, et al. Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2022;19(6):351\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"36","key":"2485_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039372","volume":"103","author":"A Akram","year":"2024","unstructured":"Akram A, Ahmed M, Farhan K, et al. Safety and efficacy of S1P receptor modulators for the induction and maintenance phases in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2024;103(36):e39372.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2485_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00011-023-01829-6","volume":"73","author":"HA Suilik","year":"2024","unstructured":"Suilik HA, Jaber F, Abuelazm M, et al. Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Inflamm Res. 2024;73(2):183\u201398.","journal-title":"Inflamm Res"},{"issue":"10","key":"2485_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334.","journal-title":"J Clin Epidemiol"},{"issue":"10383","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(23)00061-2","volume":"401","author":"WJ Sandborn","year":"2023","unstructured":"Sandborn WJ, Vermeire S, Peyrin-Biroulet L, et al. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. The Lancet. 2023;401(10383):1159\u201371.","journal-title":"The Lancet"},{"issue":"7414","key":"2485_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"2485_CR22","unstructured":"Higgins JPT, Thomas J, Chandler J, et al, editor(s). (2024) Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane. Available from www.cochrane.org\/handbook"},{"issue":"7109","key":"2485_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"14","key":"2485_CR24","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","volume":"385","author":"WJ Sandborn","year":"2021","unstructured":"Sandborn WJ, Feagan BG, D\u2019Haens G, et al. Ozanimod as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2021;385(14):1280\u201391.","journal-title":"N Engl J Med"},{"key":"2485_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"4","key":"2485_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"18","key":"2485_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","volume":"374","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn WJ, Feagan BG, Wolf DC, et al. Ozanimod induction and maintenance treatment for ulcerative colitis. N Engl J Med. 2016;374(18):1754\u201362.","journal-title":"N Engl J Med"},{"issue":"3","key":"2485_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.gastro.2019.10.035","volume":"158","author":"WJ Sandborn","year":"2020","unstructured":"Sandborn WJ, Peyrin-Biroulet L, Zhang J, et al. Efficacy and safety of etrasimod in a phase 2 randomized trial of patients with ulcerative colitis. Gastroenterology. 2020;158(3):550\u201361.","journal-title":"Gastroenterology"},{"issue":"2","key":"2485_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5217\/ir.2024.00213","volume":"24","author":"K Takeuchi","year":"2026","unstructured":"Takeuchi K, Nakase H, Hisamatsu T, et al. Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study. Intest Res. 2026;24(2):352\u201365.","journal-title":"Intest Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02485-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:02:09Z","timestamp":1790452929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02485-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,2]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02485-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,2]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}